TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Astrazeneca AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
66,143
|
60,949
|
55,766 |
| Financial expenses |
75
|
56
|
50 |
| Earnings before taxes |
3,201
|
2,448
|
1,484 |
| Total assets |
45,680
|
45,147
|
42,464 |
| Current assets |
45,503
|
45,013
|
42,300 |
| Current liabilities |
10,202
|
9,741
|
6,897 |
| Equity capital |
35,410
|
35,407
|
35,339 |
| - share capital |
10,235
|
10,930
|
11,536 |
| Employees (average) | 86 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
77.5%
|
78.4%
|
83.2% |
| Turnover per employee | 709 | ||
| Profit as a percentage of turnover |
4.8%
|
4.0%
|
2.7% |
| Return on assets (ROA) |
7.2%
|
5.5%
|
3.6% |
| Current ratio |
446.0%
|
462.1%
|
613.3% |
| Return on equity (ROE) |
9.0%
|
6.9%
|
4.2% |
| Change turnover |
9,067
|
8,112
|
-2,756 |
| Change turnover % |
16%
|
15%
|
-5% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.